Skip to main content
Top
Published in: Molecular Cancer 1/2007

Open Access 01-12-2007 | Research

hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands

Authors: Mohamed M Desouki, Joseph Geradts, Beatrice Milon, Renty B Franklin, Leslie C Costello

Published in: Molecular Cancer | Issue 1/2007

Login to get access

Abstract

Background

The normal human prostate glandular epithelium has the unique function of accumulating high levels of zinc. In prostate cancer this capability is lost as an early event in the development of the malignant cells. The mechanism and factors responsible for the ability of the normal epithelial cells to accumulate zinc and the loss of this capability in the malignant cells need to be identified. We previously reported that Zip1 is an important zinc uptake transporter in prostate cells and is down regulated in the malignant cells in situ along with the depletion of zinc levels. In this report we investigated the expression of two other Zip family zinc transporters, Zip2 and Zip3 in malignant versus nonmalignant (normal and BPH) glands. Zip2 and Zip3 relative protein levels were determined by immunohistochemistry analysis of human prostate tissue sections.

Results

Normal and BPH glandular epithelium consistently exhibited the strong presence of both Zip 2 and Zip3; whereas both transporters consistently were essentially non-detectable in the malignant glands. This represents the first report of the expression of Zip3 in human prostate tissue; and more importantly, reveals that ZiP2 and Zip3 are down regulated in malignant cells in situ as we also had demonstrated for Zip1. Zip2 and Zip3 transporter proteins were localized predominantly at the apical cell membrane, which is in contrast to the Zip1 localization at the basolateral membrane. Zip2 and Zip3 seemingly are associated with the re-uptake of zinc from prostatic fluid.

Conclusion

These results coupled with previous reports implicate Zip2 and Zip3 along with Zip1 as important zinc uptake transporters involved in the unique ability of prostate cells to accumulate high cellular zinc levels. Zip1 is important for the extraction of zinc from circulation as the primary source of cellular zinc. Zip 2 and Zip3 appear to be important for retention of the zinc in the cellular compartment. The down regulation of all three transporters in the malignant cells is consistent with the loss of zinc accumulation in these cells. Since zinc imposes tumor suppressor effects, the silencing of the gene expression for these transporters is a required event for the manifestation of the malignant activities of the neoplastic cells. This now provides new insights into the genetic/molecular events associated with the development of prostate cancer; and supports our concept of Zip1, and now Zip2 and Zip3, as tumor suppressor genes and zinc as a tumor suppressor agent.
Appendix
Available only for authorised users
Literature
1.
go back to reference Franklin RB, Costello LC: Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007 Mar 16; Franklin RB, Costello LC: Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007 Mar 16;
2.
go back to reference Costello LC, Franklin RB: The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer. 5: 17-2006 May 15; Costello LC, Franklin RB: The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer. 5: 17-2006 May 15;
3.
go back to reference Franklin RB, Milon B, Feng P, Costello LC: Zinc and zinc transporter in normal prostate function and the pathogenesis of prostate cancer. Frontiers in Bioscience. 2005, 10: 2230-2239. 10.2741/1692PubMedCentralCrossRefPubMed Franklin RB, Milon B, Feng P, Costello LC: Zinc and zinc transporter in normal prostate function and the pathogenesis of prostate cancer. Frontiers in Bioscience. 2005, 10: 2230-2239. 10.2741/1692PubMedCentralCrossRefPubMed
4.
go back to reference Costello LC, Liu Y, Zou J, Franklin RB: Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem. 1999, 274: 17499-17504. 10.1074/jbc.274.25.17499CrossRefPubMed Costello LC, Liu Y, Zou J, Franklin RB: Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem. 1999, 274: 17499-17504. 10.1074/jbc.274.25.17499CrossRefPubMed
5.
go back to reference Franklin RB, Ma J, Zou J, Guan Z, Kukoyi BI, Feng P, Costello LC: Human Zip1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorgan Biochem. 2003, 96: 435-442. 10.1016/S0162-0134(03)00249-6.CrossRef Franklin RB, Ma J, Zou J, Guan Z, Kukoyi BI, Feng P, Costello LC: Human Zip1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorgan Biochem. 2003, 96: 435-442. 10.1016/S0162-0134(03)00249-6.CrossRef
6.
go back to reference Franklin RB, Feng P, Milon BC, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC: hZip1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer. 2005, 4: 32- 10.1186/1476-4598-4-32PubMedCentralCrossRefPubMed Franklin RB, Feng P, Milon BC, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC: hZip1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer. 2005, 4: 32- 10.1186/1476-4598-4-32PubMedCentralCrossRefPubMed
7.
go back to reference Rishi I, Baidouri H, Abbasi JA, Bullard-Dilland R, Kajdacsy-Balla A, Pestaner JP, Skacel M, Tubbs R, Bagasra O: Prostate cancer in African American men is associated with downregulation of zinc transporters. Appl Immunohistochem Mol Morphol. 2003, 11: 253-260.CrossRefPubMed Rishi I, Baidouri H, Abbasi JA, Bullard-Dilland R, Kajdacsy-Balla A, Pestaner JP, Skacel M, Tubbs R, Bagasra O: Prostate cancer in African American men is associated with downregulation of zinc transporters. Appl Immunohistochem Mol Morphol. 2003, 11: 253-260.CrossRefPubMed
8.
go back to reference Singh KK, Desouki MM, Franklin RB, Costello LC: Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol Cancer. 5: 14-2006 Apr 4; Singh KK, Desouki MM, Franklin RB, Costello LC: Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol Cancer. 5: 14-2006 Apr 4;
9.
go back to reference Huang L, Kirschke CP, Zhang Y: Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int. 2006, 31. 10.10.1186/1475-2867-6-10.CrossRef Huang L, Kirschke CP, Zhang Y: Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int. 2006, 31. 10.10.1186/1475-2867-6-10.CrossRef
10.
go back to reference Gaither AL, Eide DJ: Functional expression of the human hZip2 zinc transporter. J Biol Chem. 2000, 275: 5560-5564. 10.1074/jbc.275.8.5560CrossRefPubMed Gaither AL, Eide DJ: Functional expression of the human hZip2 zinc transporter. J Biol Chem. 2000, 275: 5560-5564. 10.1074/jbc.275.8.5560CrossRefPubMed
11.
go back to reference Costello LC, Liu Y, Franklin RB, Kennedy MC: Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem. 1997, 272: 28875-28881. 10.1074/jbc.272.46.28875CrossRefPubMed Costello LC, Liu Y, Franklin RB, Kennedy MC: Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem. 1997, 272: 28875-28881. 10.1074/jbc.272.46.28875CrossRefPubMed
12.
go back to reference Costello LC, Franklin RB, Liu Y, Kennedy MC: Zinc causes a shift toward citrate at equilibrium of the m-aconitase reaction of prostate mitochondria. J Inorg Biochem. 2000, 78: 161-165. 10.1016/S0162-0134(99)00225-1CrossRefPubMed Costello LC, Franklin RB, Liu Y, Kennedy MC: Zinc causes a shift toward citrate at equilibrium of the m-aconitase reaction of prostate mitochondria. J Inorg Biochem. 2000, 78: 161-165. 10.1016/S0162-0134(99)00225-1CrossRefPubMed
13.
go back to reference Liang J-Y, Liu Y-Y, Zou J, Franklin RB, Costello LC, Feng P: Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate. 1999, 40: 200-207. 10.1002/(SICI)1097-0045(19990801)40:3<200::AID-PROS8>3.0.CO;2-3PubMedCentralCrossRefPubMed Liang J-Y, Liu Y-Y, Zou J, Franklin RB, Costello LC, Feng P: Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate. 1999, 40: 200-207. 10.1002/(SICI)1097-0045(19990801)40:3<200::AID-PROS8>3.0.CO;2-3PubMedCentralCrossRefPubMed
14.
go back to reference Feng P, Li T-L, Guan Z-X, Franklin RB, Costello LC: Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate. 2002, 52: 311-318. 10.1002/pros.10128PubMedCentralCrossRefPubMed Feng P, Li T-L, Guan Z-X, Franklin RB, Costello LC: Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate. 2002, 52: 311-318. 10.1002/pros.10128PubMedCentralCrossRefPubMed
15.
go back to reference Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N, Kolenko VM: Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents. Clin Cancer Res. 2002, 8: 3579-3583.PubMed Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N, Kolenko VM: Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents. Clin Cancer Res. 2002, 8: 3579-3583.PubMed
16.
go back to reference Ishii K, Otsuka T, Iguchi K, Usui S, Yamamoto H, Sugimura Y, Yoshikawa K, Hayward SW, Hirano K: Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett. 2004, 207: 79-87. 10.1016/j.canlet.2003.09.029CrossRefPubMed Ishii K, Otsuka T, Iguchi K, Usui S, Yamamoto H, Sugimura Y, Yoshikawa K, Hayward SW, Hirano K: Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett. 2004, 207: 79-87. 10.1016/j.canlet.2003.09.029CrossRefPubMed
17.
go back to reference Ishii K, Usui S, Sugimura Y, Yoshida S, Hioki T, Tatematsu M, Yamamoto H, Hirano K: Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion. Int J Cancer. 2001, 92: 49-54. 10.1002/1097-0215(200102)9999:9999<::AID-IJC1161>3.0.CO;2-SCrossRefPubMed Ishii K, Usui S, Sugimura Y, Yoshida S, Hioki T, Tatematsu M, Yamamoto H, Hirano K: Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion. Int J Cancer. 2001, 92: 49-54. 10.1002/1097-0215(200102)9999:9999<::AID-IJC1161>3.0.CO;2-SCrossRefPubMed
18.
go back to reference Desouki MM, Rowan BG: SRC kinase and mitogen-activated protein kinases in the progression from normal to malignant endometrium. Clin Cancer Res. 2004, 10: 546-555. 10.1158/1078-0432.CCR-0661-03CrossRefPubMed Desouki MM, Rowan BG: SRC kinase and mitogen-activated protein kinases in the progression from normal to malignant endometrium. Clin Cancer Res. 2004, 10: 546-555. 10.1158/1078-0432.CCR-0661-03CrossRefPubMed
Metadata
Title
hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands
Authors
Mohamed M Desouki
Joseph Geradts
Beatrice Milon
Renty B Franklin
Leslie C Costello
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2007
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-6-37

Other articles of this Issue 1/2007

Molecular Cancer 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine